DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Fermenta Biotech Limited — Press Release

NSE 28 min ago·5 Nov 2026, 8:19 am

Fermenta Biotech

Fermenta Biotech has announced its unaudited financial results for the first half of fiscal year 2027. The company has submitted this information to the stock exchanges to ensure transparency and keep investors updated on its recent performance.

This disclosure is a routine regulatory requirement that allows the market to assess the company's current financial health. For investors, it provides a snapshot of Fermenta's operations and profitability during the initial period of the financial year.

Investors should focus on the company's revenue growth, operating margins, and cash flow position within the released figures. Keeping an eye on the management's commentary on future outlook will also be important to gauge the company's trajectory.